PuSH - Publication Server of Helmholtz Zentrum München

Pérez de Lema, G.* ; Maier, H.* ; Franz, T.J. ; Escribese, M.* ; Chilla, S.* ; Segerer, S.* ; Camarasa, N.* ; Schmid, H.* ; Banas, B.* ; Kalaydjiev, S. ; Busch, D.H. ; Pfeffer, K.* ; Mampaso, F.* ; Schlöndorff, D.* ; Luckow, B.*

Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.

J. Am. Soc. Nephrol. 16, 3592-3601 (2005)
PMC
Open Access Gold as soon as Publ. Version/Full Text is submitted to ZB.
MRL/MpJ-Fas(lpr)/J (MRL/lpr) mice represent a well-established mouse model of human systemic lupus erythematosus. MRL/lpr mice homozygous for the spontaneous lymphoproliferation mutation (lpr) are characterized by systemic autoimmunity, massive lymphadenopathy associated with proliferation of aberrant T cells, splenomegaly, hypergammaglobulinemia, arthritis, and fatal immune complex-mediated glomerulonephritis. It was reported previously that steady-state mRNA levels for the chemokine (C-C motif) receptor 2 (Ccr2) continuously increase in kidneys of MRL/lpr mice. For examining the role of Ccr2 for development and progression of immune complex-mediated glomerulonephritis, Ccr2-deficient mice were generated and backcrossed onto the MRL/lpr genetic background. Ccr2-deficient MRL/lpr mice developed less lymphadenopathy, had less proteinuria, had reduced lesion scores, and had less infiltration by T cells and macrophages in the glomerular and tubulointerstitial compartment. Ccr2-deficient MRL/lpr mice survived significantly longer than MRL/lpr wild-type mice despite similar levels of circulating immunoglobulins and comparable immune complex depositions in the glomeruli of both groups. Anti-dsDNA antibody levels, however, were reduced in the absence of Ccr2. The frequency of CD8+ T cells in peripheral blood was significantly lower in Ccr2-deficient MRL/lpr mice. Thus Ccr2 deficiency influenced not only monocyte/macrophage and T cell infiltration in the kidney but also the systemic T cell response in MRL/lpr mice. These data suggest an important role for Ccr2 both in the general development of autoimmunity and in the renal involvement of the lupus-like disease. These results identify Ccr2 as an additional possible target for the treatment of lupus nephritis.
Impact Factor
Scopus SNIP
Altmetric
0.000
0.000
Tags
GMC
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Language english
Publication Year 2005
HGF-reported in Year 0
ISSN (print) / ISBN 1046-6673
e-ISSN 1533-3450
Quellenangaben Volume: 16, Issue: 12, Pages: 3592-3601 Article Number: , Supplement: ,
Publisher American Society of Nephrology
Reviewing status Peer reviewed
PubMed ID 16267157
Erfassungsdatum 2005-12-31